|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO EXP |
baohuoside I results in decreased expression of ABCB11 mRNA; baohuoside I results in decreased expression of ABCB11 protein |
CTD |
PMID:35802278 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
ISO EXP |
baohuoside I results in decreased expression of ABCC2 mRNA; baohuoside I results in decreased expression of ABCC2 protein |
CTD |
PMID:35802278 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
EXP |
baohuoside I results in decreased phosphorylation of AKT1 protein baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:25119583 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
AKT1S1 |
AKT1 substrate 1 |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein] baohuoside I results in decreased phosphorylation of AKT1S1 protein |
CTD |
PMID:25119583 |
|
NCBI chr19:49,869,033...49,878,356
Ensembl chr19:49,869,033...49,878,459
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
increases expression increases secretion |
ISO |
baohuoside I results in increased expression of ALPL mRNA baohuoside I results in increased secretion of ALPL protein |
CTD |
PMID:17764702 PMID:35802278 |
|
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
baohuoside I results in increased expression of BAX protein |
CTD |
PMID:22687635 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression |
EXP |
baohuoside I results in decreased expression of BCL2 protein |
CTD |
PMID:22687635 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
increases expression |
ISO |
baohuoside I results in increased expression of BGLAP mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
decreases phosphorylation multiple interactions |
EXP |
baohuoside I results in decreased phosphorylation of BRAF protein baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of BRAF protein] |
CTD |
PMID:25119583 |
|
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
|
|
G |
CASP3 |
caspase 3 |
increases cleavage increases activity |
EXP |
baohuoside I results in increased cleavage of CASP3 protein baohuoside I results in increased activity of CASP3 protein |
CTD |
PMID:19289254 PMID:22687635 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
increases activity |
EXP |
baohuoside I results in increased activity of CASP8 protein |
CTD |
PMID:19289254 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases activity increases cleavage |
EXP |
baohuoside I results in increased activity of CASP9 protein baohuoside I results in increased cleavage of CASP9 protein |
CTD |
PMID:19289254 PMID:22687635 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
increases expression |
ISO |
baohuoside I results in increased expression of COL1A2 mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
ISO EXP |
baohuoside I results in increased expression of CYP7A1 mRNA; baohuoside I results in increased expression of CYP7A1 protein |
CTD |
PMID:35802278 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of BRAF protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MTOR protein] |
CTD |
PMID:25119583 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] baohuoside I results in decreased phosphorylation of EGFR protein |
CTD |
PMID:25119583 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions |
EXP |
baohuoside I binds to and results in increased degradation of ESR1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [baohuoside I results in increased degradation of ESR1 protein]; ESR1 inhibits the reaction [baohuoside I results in decreased expression of and affects the localization of NR0B2 protein] |
CTD |
PMID:35802278 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
increases secretion |
ISO EXP |
baohuoside I results in increased secretion of GOT1 protein |
CTD |
PMID:35802278 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GPT |
glutamic--pyruvic transaminase |
increases secretion |
ISO EXP |
baohuoside I results in increased secretion of GPT protein |
CTD |
PMID:35802278 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
decreases phosphorylation |
EXP |
baohuoside I results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:25119583 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] baohuoside I results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:25119583 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein] baohuoside I results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:25119583 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
decreases expression |
EXP |
baohuoside I results in decreased expression of MKI67 protein |
CTD |
PMID:25119583 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MTOR protein] baohuoside I results in decreased phosphorylation of MTOR protein |
CTD |
PMID:25119583 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
NOS2 |
nitric oxide synthase 2 |
decreases expression |
EXP |
baohuoside I results in decreased expression of NOS2 |
CTD |
PMID:19289254 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
decreases expression multiple interactions |
ISO EXP |
baohuoside I results in decreased expression of NR0B2 mRNA; baohuoside I results in decreased expression of NR0B2 protein baohuoside I results in decreased expression of and results in decreased activity of and affects the localization of NR0B2 protein; ESR1 inhibits the reaction [baohuoside I results in decreased expression of and affects the localization of NR0B2 protein] |
CTD |
PMID:35802278 |
|
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
decreases expression |
EXP ISO |
baohuoside I results in decreased expression of NR1H4 mRNA; baohuoside I results in decreased expression of NR1H4 protein |
CTD |
PMID:35802278 |
|
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
EXP |
baohuoside I results in increased cleavage of PARP1 protein Dinoprostone inhibits the reaction [baohuoside I results in increased cleavage of PARP1 protein]; PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein] |
CTD |
PMID:19289254 PMID:22687635 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PDPK1 |
3-phosphoinositide dependent protein kinase 1 |
decreases phosphorylation |
EXP |
baohuoside I results in decreased phosphorylation of PDPK1 protein |
CTD |
PMID:25119583 |
|
NCBI chr16:2,538,021...2,603,188
Ensembl chr16:2,537,979...2,603,188
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions |
EXP |
baohuoside I results in decreased expression of PTGS2 [baohuoside I results in decreased expression of PTGS2] which results in decreased abundance of Dinoprostone; PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein] |
CTD |
PMID:19289254 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
SLC10A1 |
solute carrier family 10 member 1 |
increases expression |
ISO EXP |
baohuoside I results in increased expression of SLC10A1 mRNA; baohuoside I results in increased expression of SLC10A1 protein |
CTD |
PMID:35802278 |
|
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
decreases expression |
EXP |
baohuoside I results in decreased expression of SLCO1A1 mRNA |
CTD |
PMID:35802278 |
|
NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
|
|
G |
TNFRSF11B |
TNF receptor superfamily member 11b |
increases expression |
ISO |
baohuoside I results in increased expression of TNFRSF11B mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
decreases expression |
ISO |
baohuoside I results in decreased expression of TNFSF11 mRNA |
CTD |
PMID:17764702 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
VEGFA |
vascular endothelial growth factor A |
decreases expression |
EXP |
baohuoside I results in decreased expression of VEGFA |
CTD |
PMID:19289254 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
OAT |
ornithine aminotransferase |
multiple interactions |
ISO |
Rhamnose inhibits the reaction [Cyclic AMP results in increased activity of OAT protein] |
CTD |
PMID:2827574 |
|
NCBI chr10:124,397,303...124,418,923
Ensembl chr10:124,397,303...124,418,976
|
|